Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand
© 2015 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Background: Non-ST elevation acute coronary syndrome (NSTE-ACS) imposes a significant health and economic burden on a society. Anticoagulants are recomme...
Saved in:
Main Authors: | Permsuwan,U., Chaiyakunapruk,N., Nathisuwan,S., Sukonthasarn,A. |
---|---|
Format: | Article |
Published: |
Wiley-Blackwell
2015
|
Subjects: | |
Online Access: | http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84925840858&origin=inward http://cmuir.cmu.ac.th/handle/6653943832/38561 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018) -
Cost-Effectiveness Analysis of Fondaparinux vs Enoxaparin in Non-ST Elevation Acute Coronary Syndrome in Thailand
by: Unchalee Permsuwan, et al.
Published: (2018) -
Medication Persistence to Lipid-lowering Agents As Cost-saving Opportunities in Indonesian Patients with Acute Coronary Syndrome after Percutaneous Coronary Intervention
by: Kristin, Erna, et al.
Published: (2022) -
High Level of Mid-Regional Proadrenomedullin during ST-Segment Elevation Myocardial Infarction Is an Independent Predictor of Adverse Cardiac Events within 90-Day Follow-Up
by: Hartopo, Anggoro Budi, et al.
Published: (2022)